Nanomedicine applications in the treatment of breast cancer: current state of the art.

about

Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.

P2860

Q47172898-EC845742-C989-4C01-99E5-789D58B17B4F Q52716381-8A941C20-401D-4159-B5E2-9B04C8300FFA

P2860

Nanomedicine applications in the treatment of breast cancer: current state of the art.

Item

http://www.wikidata.org/entity/Q41483629

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Nanomedicine applications in the treatment of breast cancer: current state of the art.

@en

type

Item

label

Nanomedicine applications in the treatment of breast cancer: current state of the art.

@en

prefLabel

Nanomedicine applications in the treatment of breast cancer: current state of the art.

@en

P1476

Nanomedicine applications in the treatment of breast cancer: current state of the art.

@en

P2093

Di Wu

http://www.w3.org/2001/XMLSchema#string

Ho-Lun Wong

http://www.w3.org/2001/XMLSchema#string

Hui-Yi Xue

http://www.w3.org/2001/XMLSchema#string

Mengjie Si

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Doxorubicin cardiomyopathy

Stromal effects on mammary gland development and breast cancer

Onivyde for the therapy of multiple solid tumors

CXCR4 in breast cancer: oncogenic role and therapeutic targeting

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition

Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine

Breast cancer metastasis: markers and models

Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Production of CNT-taxol-embedded PCL microspheres using an ammonium-based room temperature ionic liquid: as a sustained drug delivery system.

P304

5879-5892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/IJN.S123437

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28860754

http://www.w3.org/2001/XMLSchema#string

P921

breast cancer

breast neoplasm

P932

5566389

http://www.w3.org/2001/XMLSchema#string

Nanomedicine applications in the treatment of breast cancer: current state of the art.

about

P2860

P2860

Nanomedicine applications in the treatment of breast cancer: current state of the art.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932